Grifols (GIFLF) Goodwill & Intangibles (2009 - 2025)
Grifols' (GIFLF) quarterly Goodwill & Intangibles came in at $11.1 billion in Q4 2025, up 0.83% on a YoY basis from $11.0 billion in Q4 2024, and up 0.83% quarter-over-quarter from $11.0 billion in Q4 2024.
Analysis
Grifols (GIFLF) Goodwill & Intangibles (2009 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Goodwill & Intangibles for 17 consecutive years, with $11.1 billion the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Goodwill & Intangibles rose 0.83% year-over-year to $11.1 billion; the trailing twelve-month figure through Dec 2025 stood at $11.1 billion (up 0.83% YoY), and the FY2025 full-year result was $10.8 billion, down 2.13% from the prior year.
- Goodwill & Intangibles advanced to $11.1 billion in Q4 2025 per GIFLF's latest filing, from $11.0 billion in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $11.1 billion in Q4 2025 and bottomed at $21.6 million in Q4 2021.
- Historically, Goodwill & Intangibles has averaged $4.6 billion across 5 years, with a median of $326.7 million in 2023.
- The sharpest annual moves came in 2021 and 2024: Goodwill & Intangibles tumbled 90.19% in 2021, then surged 3278.68% in 2024.
- Over 5 years, Goodwill & Intangibles stood at $21.6 million in 2021, then jumped by 1334.25% to $309.8 million in 2022, then rose by 5.46% to $326.7 million in 2023, then soared by 3278.68% to $11.0 billion in 2024, then advanced by 0.83% to $11.1 billion in 2025.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $11.1 billion, $11.0 billion, and $326.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 11.13 Bn |
| Dec 31, 2024 | 11.04 Bn |
| Dec 31, 2023 | 326.68 Mn |
| Dec 31, 2022 | 309.77 Mn |
| Dec 31, 2021 | 21.60 Mn |
| Dec 31, 2020 | 220.27 Mn |
| Sep 30, 2020 | 8.95 Bn |
| Mar 31, 2020 | 8.61 Bn |
| Dec 31, 2019 | 8.46 Bn |
| Sep 30, 2019 | 8.77 Bn |
| Mar 31, 2019 | 8.43 Bn |
| Dec 31, 2018 | 7.53 Bn |
| Sep 30, 2018 | 7.65 Bn |
| Jun 30, 2018 | 7.56 Bn |
| Mar 31, 2018 | 7.11 Bn |
| Dec 31, 2017 | 6.90 Bn |
| Jun 30, 2017 | 6.74 Bn |
| Dec 31, 2016 | 5.23 Bn |
| Sep 30, 2016 | 5.11 Bn |
| Jun 30, 2016 | 5.20 Bn |